NCT04118010View on ClinicalTrials.gov

Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Cystic FibrosisDysbiosis
Interventions
DRUG

Vitamin D3

High-dose vitamin D3 50,000 IU /week for 12 weeks

DRUG

Placebo vitamin D3

Matching to Vitamin D3 placebo capsules for 12 weeks

DRUG

Inulin

Chicory-derived prebiotic inulin 12 g/day for 12 weeks

DRUG

Placebo Inulin

Corn-derived maltodextrin 12g/day as the prebiotic placebo for 12 weeks

Trial Locations (1)

30322

Emory Clinic, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT04118010 - Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis | Biotech Hunter | Biotech Hunter